These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20357980)
1. Cost (non)-recovery by platform technology facilities in the Bio21 Cluster. Gibbs G; Clark S; Quinn J; Gleeson MJ J Biomol Tech; 2010 Apr; 21(1):29-34. PubMed ID: 20357980 [TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
3. Gold in the ivory tower: equity rewards of outlicensing. Edwards M; Murray F; Yu R Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129 [TBL] [Abstract][Full Text] [Related]
4. Valid clinical research and reimbursement for what we do. Hillman BJ J Am Coll Radiol; 2005 Jan; 2(1):3-4. PubMed ID: 17411751 [No Abstract] [Full Text] [Related]
5. A venture capital view of challenges, opportunities, and innovation in biomedical research. Ratcliffe LT Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935 [TBL] [Abstract][Full Text] [Related]
6. Fundamentals of financial statement analysis for academic physician managers. Danzi JT; Boom ML Acad Med; 1998 Apr; 73(4):363-9. PubMed ID: 9580712 [TBL] [Abstract][Full Text] [Related]
7. Chasing biotech across Europe. Nasto B Nat Biotechnol; 2008 Mar; 26(3):283-8. PubMed ID: 18327234 [No Abstract] [Full Text] [Related]
8. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
9. U.S. National Institutes of Health core consolidation-investing in greater efficiency. Chang MC; Birken S; Grieder F; Anderson J J Biomol Tech; 2015 Apr; 26(1):1-3. PubMed ID: 25649473 [TBL] [Abstract][Full Text] [Related]
11. Australia. Last-ditch effort to save center at vanguard of stem cell research. Finkel E Science; 2008 Oct; 322(5901):524-5. PubMed ID: 18948515 [No Abstract] [Full Text] [Related]
13. The Blue Cross Blue Shield Association Technology Evaluation Center: how we evaluate radiology technologies. Ziegler KM; Flamm CR; Aronson N J Am Coll Radiol; 2005 Jan; 2(1):33-8. PubMed ID: 17411757 [TBL] [Abstract][Full Text] [Related]
14. Metrics for Success: Strategies for Enabling Core Facility Performance and Assessing Outcomes. Turpen PB; Hockberger PE; Meyn SM; Nicklin C; Tabarini D; Auger JA J Biomol Tech; 2016 Apr; 27(1):25-39. PubMed ID: 26848284 [TBL] [Abstract][Full Text] [Related]
16. Financing development stage biotechnology companies: RMs vs. IPOs. Ahn MJ; Couch RB; Wu W J Health Care Finance; 2011; 38(1):32-54. PubMed ID: 22043645 [TBL] [Abstract][Full Text] [Related]
17. The cost of rural health services in Papua New Guinea. Mitchell M; Thomason J; Donaldson D; Garner P P N G Med J; 1991 Dec; 34(4):276-84. PubMed ID: 1799090 [TBL] [Abstract][Full Text] [Related]
18. Implementing a low-cost web-based clinical trial management system for community studies: a case study. Geyer J; Myers K; Vander Stoep A; McCarty C; Palmer N; DeSalvo A Clin Trials; 2011 Oct; 8(5):634-44. PubMed ID: 21813582 [TBL] [Abstract][Full Text] [Related]